TCL Archive NCAB Urges Reprogramming If Needed To Assure $150 Million For Construction Through FY 1985 June 8, 1979
TCL Archive FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March. January 21, 2005
TCL Archive Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic May 30, 2014
TCL Archive Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival October 29, 2010
